Arthur Melms

13.7k total citations · 2 hit papers
146 papers, 8.5k citations indexed

About

Arthur Melms is a scholar working on Neurology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Arthur Melms has authored 146 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Neurology, 49 papers in Immunology and 21 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Arthur Melms's work include Myasthenia Gravis and Thymoma (54 papers), T-cell and B-cell Immunology (32 papers) and Peripheral Neuropathies and Disorders (28 papers). Arthur Melms is often cited by papers focused on Myasthenia Gravis and Thymoma (54 papers), T-cell and B-cell Immunology (32 papers) and Peripheral Neuropathies and Disorders (28 papers). Arthur Melms collaborates with scholars based in Germany, United States and United Kingdom. Arthur Melms's co-authors include Heinz Wiendl, Angela Vincent, Sigrun Helms, Werner Hoch, John Newsom–Davis, John McConville, Michael Weller, Berthold Schalke, Eva Tolosa and Jan J.G.M. Verschuuren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Arthur Melms

142 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

2001 839 citations Arthur Melms et al. profile →
International consensus guidance for management of myasthenia gravis

2016 710 citations Donald B. Sanders, Gil I. Wolfe et al. Neurology profile →

Peers

Countries citing papers authored by Arthur Melms

Since Specialization

Citations

This map shows the geographic impact of Arthur Melms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur Melms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur Melms more than expected).

Fields of papers citing papers by Arthur Melms

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur Melms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur Melms. The network helps show where Arthur Melms may publish in the future.

Co-authorship network of co-authors of Arthur Melms

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur Melms. A scholar is included among the top collaborators of Arthur Melms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur Melms. Arthur Melms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	INTERNATIONAL CONSENSUS GUIDANCE FOR THE MANAGEMENT OF MYASTHENIA GRAVIS 2016 ·Muscle & Nerve ·Donald B. Sanders, (unknown), Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami	0
2	International consensus guidance for management of myasthenia gravis breakdown → 2016 ·Neurology ·Donald B. Sanders, Gil I. Wolfe, Michael Benatar, Amelia Evoli, Nils Erik Gilhus, Isabel Illa, Nancy L. Kuntz, Janice M. Massey, Arthur Melms, Hiroyuki Murai, Michael Nicolle, Jacqueline Palace, David P. Richman, Jan J.G.M. Verschuuren, Pushpa Narayanaswami	710
3	Prednisolone Treatment Induces Tolerogenic Dendritic Cells and a Regulatory Milieu in Myasthenia Gravis Patients 2009 ·The Journal of Immunology ·Claudia Luther, Eleni Adamopoulou, Christina Stoeckle, Verena Brucklacher-Waldert, Daniela Rosenkranz, Lars Stoltze, (unknown), (unknown), Arthur Melms, Eva Tolosa	71
4	An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis 2008 ·Neurology ·Donald B. Sanders, I. K. Hart, Renato Mantegazza, Shailja Shukla, Zaeem A. Siddiqi, (unknown), Arthur Melms, Michael Nicolle, N. Solomons, David P. Richman	186
5	Cathepsin G is differentially expressed in primary human antigen-presenting cells 2008 ·Cellular Immunology ·Christina Stoeckle, (unknown), Eleni Adamopoulou, (unknown), Stephan Schiekofer, Arthur Melms, Ekkehard Weber, Christoph Driessen, Bernhard O. Boehm, Eva Tolosa, Timo Burster	23
6	Induction of Autoimmunity by Expansion of Autoreactive CD4+CD62Llow Cells In Vivo 2006 ·The Journal of Immunology ·Bastian Amend, (unknown), Christian Lange, Evelyn Dubois, Hubert Kalbacher, Arthur Melms, Felix Bischof	16
7	Thymus and myasthenia gravis: antigen processing in the human thymus and the consequences for the generation of autoreactive T cells 2006 ·Acta Neurologica Scandinavica ·Arthur Melms, Claudia Luther, Christina Stoeckle, Simone Pöschel, (unknown), Mikael Varga, Wolfgang Wienhold, Eva Tolosa	16
8	Analysis of Autoreactive CD4 T Cells in Experimental Autoimmune Encephalomyelitis after Primary and Secondary Challenge Using MHC Class II Tetramers 2004 ·The Journal of Immunology ·Felix Bischof, Matthias Hofmann, Ton N. Schumacher, Florry A. Vyth‐Dreese, Robert Weissert, Hansjörg Schild, Ada M. Kruisbeek, Arthur Melms	39
9	MHC Class II Isotype- and Allele-Specific Attenuation of Experimental Autoimmune Encephalomyelitis 2004 ·The Journal of Immunology ·Katrien L. de Graaf, (unknown), (unknown), Maria K. Storch, Christoph Otto, Tomas Olsson, Arthur Melms, Günther Jung, Karl‐Heinz Wiesmüller, Robert Weissert	8
10	A Structurally Available Encephalitogenic Epitope of Myelin Oligodendrocyte Glycoprotein Specifically Induces a Diversified Pathogenic Autoimmune Response 2004 ·The Journal of Immunology ·Felix Bischof, Adriaan D. Bins, Michael Dürr, (unknown), Arthur Melms, Ada M. Kruisbeek	20
11	Cathepsin G, and Not the Asparagine-Specific Endoprotease, Controls the Processing of Myelin Basic Protein in Lysosomes from Human B Lymphocytes 2004 ·The Journal of Immunology ·Timo Burster, Alexander Beck, Eva Tolosa, Viviana Marin‐Esteban, Olaf Rötzschke, Kirsten Falk, Alfred Lautwein, Michael Reich, Jens Brandenburg, Gerold Schwarz, Heinz Wiendl, Arthur Melms, Rainer Lehmann, Stefan Stevanović, Hubert Kalbacher, Christoph Driessen	63
12	Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis 2003 ·Journal of Clinical Investigation ·Eva Tolosa, Weijie Li, Yoshiyuki Yasuda, Wolfgang Wienhold, Lisa Denzin, Alfred Lautwein, Christoph Driessen, Petra Schnorrer, Ekkehard Weber, Stefan Stevanović, Raffael Kurek, Arthur Melms, Dieter Brömme	104
13	A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape 2002 ·The Journal of Immunology ·Heinz Wiendl, Meike Mitsdoerffer, Valeska Hofmeister, Jörg Wischhusen, Antje Bornemann, Richard Meyermann, Elisabeth H. Weiss, Arthur Melms, Michael Weller	291
14	High Immunogenicity of Intracellular Myelin Oligodendrocyte Glycoprotein Epitopes 2002 ·The Journal of Immunology ·Robert Weissert, Jens Kühle, Katrien L. de Graaf, Wolfgang Wienhold, (unknown), Claudia Müller, Thomas G. Forsthuber, Karl‐Heinz Wiesmüller, Arthur Melms	41
15	T Cell Epitopes of Human Myelin Oligodendrocyte Glycoprotein Identified in HLA-DR4 (DRB10401) Transgenic Mice Are Encephalitogenic and Are Presented by Human B Cells 2001 ·The Journal of Immunology* ·Thomas G. Forsthuber, Carey L. Shive, Wolfgang Wienhold, (unknown), Edward G. Spack, R D Sublett, Arthur Melms, Jens Kort, Michael K. Racke, Robert Weissert	71
16	Immunoglobulin isotypes reveal a predominant role of type 1 immunity in multiple sclerosis 2001 ·Journal of Neuroimmunology ·Bernhard Greve, Carl Magnusson, Arthur Melms, Robert Weissert	26
17	MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation 1998 ·European Journal of Immunology ·Georg Malcherek, Christoph Wirblich, Nicholas Willcox, Hans‐Georg Rammensee, John Trowsdale, Arthur Melms	43
18	Ocular myasthenia gravis: response to long term immunosuppressive treatment 1997 ·American Journal of Ophthalmology ·(unknown), Arthur Melms, Michael Weller, Karsten Schepelmann, Volker Herzau, Johannes Dichgans, Norbert Sommer	6
19	Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. 1989 ·Journal of Clinical Investigation ·Arthur Melms, (unknown), Berthold Schalke, Hartmut Wekerle, Alex Mauron, Marc Ballivet, T. Barkas	55
20	Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. 1988 ·Journal of Clinical Investigation ·Arthur Melms, Berthold Schalke, T Kirchner, H. K. Müller-Hermelink, E. D. Albert, Hartmut Wekerle	125

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact